Search results
Author(s):
Demosthenes G Katritsis
,
Ioannis Pantos
Added:
3 years ago
The functional severity of atherosclerotic coronary lesions is the single most important prognostic factor in patients with documented coronary artery disease (CAD). Assessment of the haemodynamic significance of coronary artery lesions by invasive fractional flow reserve (FFR) measurement now has an I-A indication by the European Society of Cardiology (ESC) to identify haemodynamically relevant…
View more
Author(s):
Ji Hyun Lee
,
Bríain ó Hartaigh
,
Donghee Han
,
et al
Added:
3 years ago
Coronary computed tomography angiography (CCTA) is a noninvasive tool capable of directly visualising the coronary anatomy with high sensitivity and negative predictive value (NPV) for coronary artery disease (CAD) compared to invasive coronary angiography (ICA).1,2 Recent innovations in computed tomography (CT) technology have led to the rapid development of CCTA and its selection as an anatomic…
View more
Author(s):
Lavinia Gabara
,
Jonathan Hinton
,
Julian P Gunn
,
et al
Added:
3 years ago
The optimal assessment and management of patients presenting with recent onset chest pain is achieved by acquiring information about the coronary anatomy and physiology, enabling decisions to be made based upon evidence of ischaemia at a patient-level and at lesion-level. There are robust data indicating that the visual assessment of stenosis severity alone does not provide enough information…
View more
Author(s):
Hirofumi Ohashi
,
Frédéric Bouisset
,
Dimitri Buytaert
,
et al
Added:
3 months ago
Author(s):
Cameron Dowling
,
Robert Gooley
,
Liam McCormick
,
et al
Added:
2 years ago
Author(s):
Joost Daemen
Added:
1 year ago
CRT 23 - In this short interview from CRT's 2023 Scientific Sessions, we are joined by Dr Joost Daemen (Thoraxcenter, Erasmus University Medical Center, NL) to outline the FAST III Trial, sponsored by the European Cardiovascular Research Institute. In this study, over 2000 patients were randomized in a 1:1 manner, to vFFR or FFR guided revascularization for the treatment of coronary artery…
View more
Author(s):
Viktor Kočka
,
Petr Widimsky
Added:
3 years ago
Terminology
When the first-in-human implantation of a bioresorbable device into the coronary artery was reported in 2007, the term ‘fully bioabsorbable stent’ was used.1 Later, in 2011, Onuma and colleagues explained that the term ‘bioresorbable’ provides a more precise description of the complete cleavage of macromolecules to small molecules with total elimination and the term ‘scaffold’ was…
View more
Author(s):
Jonathon A Leipsic
,
Jonathan Weir-McCall
,
Philipp Blanke
Added:
3 years ago
Coronary CTA has rapidly gone from a test with potential to be considered a first-line test for patients with stable chest pain.1 It provides robust ability to exclude atherosclerosis and coronary artery stenosis and more recently has been shown to inform and guide clinical treatment making in a fashion that enables a reduction in myocardial infarction when compared to traditional stress testing…
View more
Author(s):
Stephan Achenbach
,
Tanja Rudolph
,
Johannes Rieber
,
et al
Added:
3 years ago
The invasive measurement of fractional flow reserve (FFR) can determine the haemodynamic relevance of coronary artery stenoses. Determination of FFR is recommended in coronary artery stenoses with a luminal diameter narrowing between 50 % and 90 % if no non-invasive proof of ischaemia is available.1 To measure the FFR of a given coronary lesion, a wire or a microcatheter equipped with a…
View more
Author(s):
Constantinos O’Mahony
,
Saidi Mohiddin
,
Charles Knight
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM) is a genetic disorder of cardiac muscle with a heterogeneous clinical course.1 The disease is clinically characterised by left ventricular hypertrophy (LVH), which is typically asymmetric, and a subgroup of patients have left ventricular outflow tract obstruction (LVOTO) caused by systolic anterior motion (SAM) of the mitral valve leaflet(s).2,3 LVOTO is often…
View more